Skip to content

An interventional study to evaluate the effect of syrup mutra sangrahaneeya mahakashaya in participients of childhood nephrotic syndrome.

A single arm open label interventional study to evaluate the efficacy of mutra sangrahaneeya mahakashaya in childhood nephrotic syndrome w.s.r. to ojo vyapada. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069889
Enrollment
30
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

None listed

Sponsors

NO SPONSER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of Minimal Change steroid dependent Nephrotic Syndrome with less than three relapses so far. 2.Diagnosed cases of Minimal Change Nephrotic Syndrome with less than nephrotic range of proteinurea (not more than 3gm/24 hr protein loss) 3.Diagnosed cases of Minimal Change Nephrotic Syndrome without any documented adverse effects of steroid therapy. 4.Diagnosed cases of Minimal Change Nephrotic Syndrome with chronicity of less than 1 year.

Exclusion criteria

Exclusion criteria: 1.Child with more than three episodes of recurrences requiring higher doses of steroid and with chronicity of more than one year and more than three relapses so far. 2.Children with gross Congenital Anomalies, urogenital anomalies 3.Children with Genetic Nephrotic Syndrome and involvement of kidney parenchyma 4.Children with Secondary Glomerulonephritis (eg. Post infectious Glomerulonephritis, SLE, Diabetic neuropathy, Henoch-Schonlein Syndrome) 5.Children of Nephrotic Syndrome with end stage disease. 6.Children receiving immune-suppressant other than steroid like cytotoxic drugs etc. with indication of renal biopsy

Design outcomes

Primary

MeasureTime frame
Change in Proteinurea in children with Minimal Change Nephrotic SyndromeTimepoint: at baseline,15th day, 30th day, 45th day, 60th day,75th dayand 90th day

Secondary

MeasureTime frame
â?¢ Change in biochemical parameters e.g., serum protein, serum cholesterol, serum creatinine â?¢ Change in quality of life & general condition of children. Timepoint: 90th day

Countries

India

Contacts

Public ContactDr Aisha Amrin Jahan Qadari

National Institute of Ayurveda, JAIPUR

ashanidhiacharya@gmail.com7877151575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026